Physician profile
Devin S Edwards
NPI 1578753521
$7,851.06
in general payments reported to CMS, 2019-2025
7 companies · $7,158 in 2025
The $7,158 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.26 · 2021: $200 · 2022: $179 · 2023: $112 · 2024: $146 · 2025: $7,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,589 · Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,588.80 |
| Food and Beverage | $327.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,132.80 | 2025 | |
| Smith+Nephew, INC. | $491.82 | 2019-2025 | Stravix Pl, Grafix Pl, Grafix Xc |
| Integra Lifesciences Corporation | $81.46 | 2024 | Tcc-Ez |
| Osiris Therapeutics INC. | $43.77 | 2019 | |
| Abbvie INC. | $40.11 | 2021-2024 | |
| Organogenesis INC. | $34.11 | 2023-2024 | Puraply |
| Urgo Medical North America, LLC | $26.99 | 2024 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.